Now showing 1 - 10 of 26
  • 2011Conference Abstract
    [["dc.bibliographiccitation.journal","European Heart Journal"],["dc.bibliographiccitation.volume","32"],["dc.contributor.author","Zabel, M."],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Wallisch, Nora"],["dc.date.accessioned","2018-11-07T08:53:55Z"],["dc.date.available","2018-11-07T08:53:55Z"],["dc.date.issued","2011"],["dc.format.extent","929"],["dc.identifier.isi","000208702706560"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/22543"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Oxford Univ Press"],["dc.publisher.place","Oxford"],["dc.relation.issn","0195-668X"],["dc.title","Effects of ranolazine on torsades de pointes in an isolated rabbit heart model"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details WOS
  • 2010Journal Article
    [["dc.bibliographiccitation.firstpage","1460"],["dc.bibliographiccitation.issue","10"],["dc.bibliographiccitation.journal","EP Europace"],["dc.bibliographiccitation.lastpage","1466"],["dc.bibliographiccitation.volume","12"],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Zabel, Markus"],["dc.contributor.author","Luethje, Lars"],["dc.contributor.author","Vollmann, Dirk"],["dc.date.accessioned","2018-11-07T08:38:23Z"],["dc.date.available","2018-11-07T08:38:23Z"],["dc.date.issued","2010"],["dc.description.abstract","Ventricular oversensing remains a significant problem in modern implantable cardioverter-defibrillator (ICD) systems. The role of manufacturer-related differences in device-based signal processing on the one hand and sensing lead properties on the other is largely unknown. This retrospective study aimed to evaluate and compare the incidence and mechanisms of ventricular oversensing in single- or dual-chamber ICD systems from Biotronik (BTK), Guidant (GDT), and Medtronic (MDT). In 245 consecutive patients, device function, stored episodes, and lead parameters were evaluated at implant and during 243 +/- 18 days of follow-up. Oversensing occurred in 3.3% of the patients [four T-wave oversensing (TWO), three R-wave double-sensing, and one diaphragmatic myopotentials]. The incidence of ventricular oversensing was generally low if an ICD device and an ICD lead were from one identical manufacturer (BTK: 2/68, GDT: 1/80, and MDT: 1/69; P = 0.67). In the subgroup of ICDs connected to leads from other manufacturers, however, ventricular oversensing was observed in none of 19 GDT and MDT ICDs but in 4 of 9 BTK devices (44.4%, P = 0.012). These four cases of oversensing (three R-wave double-sensing and one TWO) all occurred in BTK ICDs connected to integrated bipolar ICD leads from other manufacturers. Significant manufacturer-related differences exist in the incidence of ventricular oversensing in single- and dual-chamber ICD systems. Biotronik devices connected to integrated bipolar ICD leads from other manufacturers have an increased risk for R-wave double-sensing."],["dc.description.sponsorship","Medtronic; Biotronik"],["dc.identifier.doi","10.1093/europace/euq269"],["dc.identifier.isi","000282429700012"],["dc.identifier.pmid","20663783"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/18757"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Oxford Univ Press"],["dc.relation.issn","1099-5129"],["dc.title","Ventricular oversensing due to manufacturer-related differences in implantable cardioverter-defibrillator signal processing and sensing lead properties"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC WOS
  • 2014Conference Abstract
    [["dc.bibliographiccitation.journal","European Heart Journal"],["dc.bibliographiccitation.volume","35"],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Hnatkova, Katerina"],["dc.contributor.author","Exposito, P. Munoz"],["dc.contributor.author","Sohns, Christian"],["dc.contributor.author","Sossalla, Samuel T."],["dc.contributor.author","Luethje, Lars"],["dc.contributor.author","HasenfuĂź, Gerd"],["dc.contributor.author","Malik, Marek"],["dc.contributor.author","Zabel, M."],["dc.date.accessioned","2018-11-07T09:35:35Z"],["dc.date.available","2018-11-07T09:35:35Z"],["dc.date.issued","2014"],["dc.format.extent","770"],["dc.identifier.isi","000343001304445"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/32419"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Oxford Univ Press"],["dc.publisher.place","Oxford"],["dc.relation.eventlocation","Barcelona, SPAIN"],["dc.relation.issn","1522-9645"],["dc.relation.issn","0195-668X"],["dc.title","T-wave morphology markers from the 12-lead surface ECG for prediction of appropriate implantable cardioverter-defibrillator discharges and all-cause mortality"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details WOS
  • 2011Journal Article
    [["dc.bibliographiccitation.firstpage","1699"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","Pacing and Clinical Electrophysiology"],["dc.bibliographiccitation.lastpage","1703"],["dc.bibliographiccitation.volume","34"],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Zabel, Markus"],["dc.contributor.author","Sweeney, Michael O."],["dc.contributor.author","Vollmann, Dirk"],["dc.date.accessioned","2018-11-07T08:49:14Z"],["dc.date.available","2018-11-07T08:49:14Z"],["dc.date.issued","2011"],["dc.description.sponsorship","Biotronik; Medtronic"],["dc.identifier.doi","10.1111/j.1540-8159.2011.03099.x"],["dc.identifier.isi","000297940700021"],["dc.identifier.pmid","21501178"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/21409"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.relation.issn","0147-8389"],["dc.title","Inappropriate Sensing in a Single-Chamber ICDuWhat is the Mechanism?"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC WOS
  • 2011Journal Article
    [["dc.bibliographiccitation.firstpage","1054"],["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","Pacing and Clinical Electrophysiology"],["dc.bibliographiccitation.lastpage","1062"],["dc.bibliographiccitation.volume","34"],["dc.contributor.author","Dorenkamp, Marc"],["dc.contributor.author","Breitwieser, Christoph"],["dc.contributor.author","Morguet, Andreas J."],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Behrens, Steffen"],["dc.contributor.author","Zabel, Markus"],["dc.date.accessioned","2018-11-07T08:52:24Z"],["dc.date.available","2018-11-07T08:52:24Z"],["dc.date.issued","2011"],["dc.description.abstract","Background: T-wave alternans (TWA) is a useful method for identifying patients who are at risk for sudden cardiac death. We aimed to determine the effects of different pacing modes on test results and long-term prognostic relevance of TWA in patients following a dual-chamber (DDD) pacemaker implantation. Methods: Sixty-three patients (mean age 68 +/- 13 years) with structural heart disease and recently implanted DDD pacemakers were enrolled. Left ventricular (LV) function was normal or moderately impaired (mean LV ejection fraction 61 +/- 13%). All patients underwent sequential TWA testing using atrial and ventricular pacing. Results: During atrial pacing requiring physiologic conduction to the ventricles, 21% of TWA tests were positive, 43% negative, and 36% indeterminate. When using right ventricular (RV) pacing in the same patients, 19% of tests were positive, 40% negative, and 41% indeterminate. When positive and indeterminate tests were grouped as nonnegative, the concordance between atrial and ventricular pacing was 62% (kappa = 0.22). After a mean follow-up of 5.9 +/- 1.9 years, 18 (29%) patients had died. Improved survival was predicted by a negative TWA test using atrial pacing (P = 0.028), but not with ventricular pacing (P = 0.722). Conclusions: In patients with dual-chamber pacemakers, there is a low concordance of TWA test results between atrial pacing with intrinsic conduction to the ventricles and apical RV pacing via pacemaker electrode. However, TWA during atrial pacing clearly exerts long-term prognostic relevance in a patient group with preserved LV function and structural heart disease. (PACE 2011; 34:1054-1062)"],["dc.identifier.doi","10.1111/j.1540-8159.2011.03101.x"],["dc.identifier.isi","000295051200005"],["dc.identifier.pmid","21501180"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/22155"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.relation.issn","0147-8389"],["dc.title","T-Wave Alternans Testing in Pacemaker Patients: Comparison of Pacing Modes and Long-Term Prognostic Relevance"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC WOS
  • 2014Conference Abstract
    [["dc.bibliographiccitation.journal","European Heart Journal"],["dc.bibliographiccitation.volume","35"],["dc.contributor.author","Exposito, P. Munoz"],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Luethje, Lars"],["dc.contributor.author","Vollmann, Dirk"],["dc.contributor.author","HasenfuĂź, Gerd"],["dc.contributor.author","Zabel, M."],["dc.date.accessioned","2018-11-07T09:35:36Z"],["dc.date.available","2018-11-07T09:35:36Z"],["dc.date.issued","2014"],["dc.format.extent","939"],["dc.identifier.isi","000343001305332"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/32422"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Oxford Univ Press"],["dc.publisher.place","Oxford"],["dc.relation.eventlocation","Barcelona, SPAIN"],["dc.relation.issn","1522-9645"],["dc.relation.issn","0195-668X"],["dc.title","Usefulness of approximate body-surface-potential-mapping (a-bspm) for risk stratification"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details WOS
  • 2014Journal Article Discussion
    [["dc.bibliographiccitation.firstpage","1076"],["dc.bibliographiccitation.issue","8"],["dc.bibliographiccitation.journal","Pacing and Clinical Electrophysiology"],["dc.bibliographiccitation.lastpage","1079"],["dc.bibliographiccitation.volume","37"],["dc.contributor.author","Sossalla, Samuel T."],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Luethje, Lars"],["dc.contributor.author","Sohns, Christian"],["dc.contributor.author","Zabel, Markus"],["dc.contributor.author","Vollmann, Dirk"],["dc.date.accessioned","2018-11-07T09:36:51Z"],["dc.date.available","2018-11-07T09:36:51Z"],["dc.date.issued","2014"],["dc.identifier.doi","10.1111/pace.12316"],["dc.identifier.isi","000342831900023"],["dc.identifier.pmid","24460891"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/32709"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.relation.issn","1540-8159"],["dc.relation.issn","0147-8389"],["dc.title","Ventricular Oversensing after ICD Lead Replacement: What Is the Mechanism?"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC WOS
  • 2014Journal Article
    [["dc.bibliographiccitation.firstpage","7"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Cardiovascular Therapeutics"],["dc.bibliographiccitation.lastpage","12"],["dc.bibliographiccitation.volume","32"],["dc.contributor.author","Sohns, Christian"],["dc.contributor.author","von Gruben, Valerie"],["dc.contributor.author","Sossalla, Samuel T."],["dc.contributor.author","Bergau, Leonard"],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Luethje, Lars"],["dc.contributor.author","Vollmann, Dirk"],["dc.contributor.author","Zabel, Markus"],["dc.date.accessioned","2018-11-07T09:44:27Z"],["dc.date.available","2018-11-07T09:44:27Z"],["dc.date.issued","2014"],["dc.description.abstract","AimsThe optimal pharmacological treatment for patients early after ablation of atrial fibrillation (AF) is still not clear. We analyzed if concomitant antiarrhythmic drug (AAD) therapy significantly alters early recurrence of AF/atrial tachycardia (AT) following pulmonary vein ablation (PVA). MethodsFor the first 2months after PVA, 274 patients (age 6210years; 66% male) were individually scheduled for concomitant treatment with beta-adrenergic blocking agents (BB) or AAD therapy. Primary endpoint of this study was a composite of (1) AF/AT lasting more than 30seconds; (2) symptomatic AF/AT recurrence requiring intervention; or (3) intolerance to the antiarrhythmic agent given. Univariate and multivariate analysis was performed to evaluate predictors for successful AAD therapy. ResultsEarly after PVA, patients were treated with BB (n=89), flecainide (n=99), sotalol (n=37), dronedarone (n=29), or amiodarone (n=115). Ninety-five patients received a combination of AAD therapy and BB. A total of 369 observation periods were analyzed. Over the first 2months following PVA, AF/AT recurrences were found in 42% of patients. No significant difference regarding freedom from AF/AT recurrence with regard to different drug therapies was observed (P=0.769). In multivariate analysis, none of the parameters were significant to predict success of AAD therapy. In nine observations, AAD therapy was terminated due to side effects presumably related to the respective agent. ConclusionsFollowing PVA, AAD therapy is not superior to BB treatment for the prevention of early atrial arrhythmias. Furthermore and confirmed by multivariate analysis, no drug was superior to another regarding the maintenance of sinus rhythm."],["dc.identifier.doi","10.1111/1755-5922.12052"],["dc.identifier.isi","000330853700002"],["dc.identifier.pmid","24138075"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/34396"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.relation.issn","1755-5922"],["dc.relation.issn","1755-5914"],["dc.title","Antiarrhythmic Drug Therapy for Maintaining Sinus Rhythm Early after Pulmonary Vein Ablation in Patients with Symptomatic Atrial Fibrillation"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC WOS
  • 2013Conference Abstract
    [["dc.bibliographiccitation.firstpage","263"],["dc.bibliographiccitation.journal","European Heart Journal"],["dc.bibliographiccitation.lastpage","264"],["dc.bibliographiccitation.volume","34"],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Exposito, P. Munoz"],["dc.contributor.author","Sohns, Christian"],["dc.contributor.author","Dorenkamp, Marc"],["dc.contributor.author","Meinel, T."],["dc.contributor.author","Luethje, Lars"],["dc.contributor.author","Vollmann, Dirk"],["dc.contributor.author","HasenfuĂź, Gerd"],["dc.contributor.author","Zabel, M."],["dc.date.accessioned","2018-11-07T09:21:33Z"],["dc.date.available","2018-11-07T09:21:33Z"],["dc.date.issued","2013"],["dc.identifier.isi","000327744601412"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/29136"],["dc.notes.status","zu prĂĽfen"],["dc.notes.submitter","Najko"],["dc.publisher","Oxford Univ Press"],["dc.publisher.place","Oxford"],["dc.relation.eventlocation","Amsterdam, NETHERLANDS"],["dc.relation.issn","1522-9645"],["dc.relation.issn","0195-668X"],["dc.title","Incidence of appropriate ICD shock after generator replacement without preceding shock: how necessary is the continued ICD therapy?"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details WOS
  • 2013Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","303"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Cardiovascular Therapeutics"],["dc.bibliographiccitation.lastpage","306"],["dc.bibliographiccitation.volume","31"],["dc.contributor.author","Sossalla, Samuel"],["dc.contributor.author","Sohns, Christian"],["dc.contributor.author","Seegers, Joachim"],["dc.contributor.author","Lüthje, Lars"],["dc.contributor.author","Vollmann, Dirk"],["dc.contributor.author","Zabel, Markus"],["dc.date.accessioned","2018-11-07T09:19:19Z"],["dc.date.available","2018-11-07T09:19:19Z"],["dc.date.issued","2013"],["dc.description.abstract","We report on a patient who was treated with several antiarrhythmic drugs as well as different ablation strategies. Nevertheless, symptomatic atrial fibrillation always recurred until an off-label use with ranolazine was started. We could demonstrate potent effects of ranolazine on atrial fibrillation in a \"wash-in wash-out\" situation. Although promising controlled studies are needed to investigate a potential role of ranolazine for the treatment of atrial fibrillation."],["dc.description.sponsorship","DFG [SFB 1002]"],["dc.identifier.doi","10.1111/1755-5922.12017"],["dc.identifier.isi","000324302900012"],["dc.identifier.pmid","23205928"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/28604"],["dc.identifier.url","https://sfb1002.med.uni-goettingen.de/production/literature/publications/58"],["dc.language.iso","en"],["dc.notes.status","final"],["dc.notes.submitter","Najko"],["dc.relation","SFB 1002: Modulatorische Einheiten bei Herzinsuffizienz"],["dc.relation","SFB 1002 | A03: Bedeutung CaMKII-abhängiger Mechanismen für die Arrhythmogenese bei Herzinsuffizienz"],["dc.relation.issn","1755-5922"],["dc.relation.issn","1755-5914"],["dc.relation.workinggroup","RG Sossalla (Kardiovaskuläre experimentelle Elektrophysiologie und Bildgebung)"],["dc.title","Ranolazine Maintained Sinus Rhythm in a Patient with Refractory Symptomatic Atrial Fibrillation"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC WOS